Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment
Shengdi Wu, Li‐Li Liu, Jilin Cheng, et al.
Clinical and Experimental Medicine (2018) Vol. 18, Iss. 3, pp. 433-443
Closed Access | Times Cited: 19

Showing 19 citing articles:

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
Zui Tan, Hongbao Sun, Taixiong Xue, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 155
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
Michelle T. Long, Sanil Gandhi, Rohit Loomba
Metabolism (2020) Vol. 111, pp. 154259-154259
Open Access | Times Cited: 60
KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease
Mi Na Kim, Ji Won Han, Jihyun An, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. Suppl, pp. S5-S105
Open Access | Times Cited: 6
Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population
Louise J. M. Alferink, Nicole S. Erler, Robert J. de Knegt, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 11, pp. 1069-1085
Open Access | Times Cited: 42
Efficacy and safety of anti-hepatic fibrosis drugs
Konstantinos Damiris, Zaid Tafesh, Nikolaos Pyrsopoulos
World Journal of Gastroenterology (2020) Vol. 26, Iss. 41, pp. 6304-6321
Open Access | Times Cited: 37
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
Dong Ji, Yan Chen, Qinghua Shang, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 8, pp. 1676-1685
Open Access | Times Cited: 27
Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial
Zhimin Zhao, Chuanwu Zhu, Jiaquan Huang, et al.
Journal of Ethnopharmacology (2022) Vol. 298, pp. 115599-115599
Open Access | Times Cited: 15
Increased liver stiffness promotes hepatitis B progression by impairing innate immunity in CCl4-induced fibrotic HBV+ transgenic mice
Grace Bybee, Youra Moeun, Weimin Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Evaluation of liver fibrosis in chronic hepatitis B patients with 2D shear wave elastography with propagation map guidance: a single-centre study
Şeyhmus Kavak, Şafak Kaya, Ayhan Şenol, et al.
BMC Medical Imaging (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort Study
Wei Xu, Qiankun Hu, Chong Chen, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 1777-1785
Open Access | Times Cited: 4
Elastography for Longitudinal Assessment of Liver Fibrosis after Antiviral Therapy: A Review
Hong Wei, Bin Song
Journal of Clinical and Translational Hepatology (2020) Vol. 8, Iss. 4, pp. 1-9
Open Access | Times Cited: 11
Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV
Jennifer Grant, Patricia Agaba, Placid Ugoagwu, et al.
Journal of Antimicrobial Chemotherapy (2019) Vol. 74, Iss. 7, pp. 2003-2008
Open Access | Times Cited: 7
Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B
Haina Fan, Zhimin Zhao, Kai Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Advances in Diagnostic Technique and Pharmacological Therapy of Hepatitis B
菁 何
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 643-652
Closed Access
Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal
Xian-Zhi Han, Shufeng Zhang, Jia-Yin Yi, et al.
Open Life Sciences (2020) Vol. 15, Iss. 1, pp. 418-422
Open Access | Times Cited: 1
The informative value of noninvasive tools for assessment of liver fibrosis in chronic hepatitis B patients under antiviral treatment with nucleoside and nucleotide analogues
T. H. Nguyen, L. Yu. Ilchenko, L. I. Melnikova, et al.
Almanac of Clinical Medicine (2023) Vol. 51, Iss. 3, pp. 171-179
Open Access
Effect of Canagliflozin on liver steatosis in obese non diabetic patients with non-alcoholicfatty liver disease: A double blind randomized controlled trial
Borwonkhun Tontivuthikul
(2019)
Open Access
Management of ACLD After HBV-Suppression and HCV-Cure
Jidong Jia, Sabela Lens, Hitoshi Yoshiji, et al.
Springer eBooks (2022), pp. 239-252
Closed Access
Elastography After Treatment and During Follow-Up
Mirella Fraquelli, Ilaria Fanetti, Andrea Costantino
Springer eBooks (2021), pp. 119-141
Closed Access
Page 1

Scroll to top